We recently had the pleasure of presenting our project to the Discovery team at Scope Fluidics – a company that has shown how bold ideas in diagnostics can evolve into global success stories.

The seminar was a valuable workshop-style meeting, where we shared the vision behind Aptamedica and the potential of our AptaSense analyzer. We received insightful feedback – both technological and strategic – that will significantly influence the next stages of our development.

We’re grateful for the in-depth analysis of our project and the thoughtful perspectives that challenged us to think bigger and refine our approach. This exchange has become a key reference point for us, marking a new beginning in the evolution of AptaSense.

We believe that our analyzer can follow a trajectory similar to breakthrough platforms like BacterOMIC or PCR|ONE. The parallels are clear – and so is the potential for future collaboration built on shared goals and complementary technologies.

Thanks to this meeting, our project is taking on sharper, more mature shapes. We’re moving forward with renewed clarity and confidence, committed to building diagnostic tools that are fast, precise, and truly impactful.